Drug Information

Drug General Information
Drug ID
D02DVK
Former ID
DIB001875
Drug Name
CV-9201
Synonyms
CV-9201-1; CV-9201-2; CV-9201-3; CV-9201-4; CV-9201-5; RNA-based vaccine (NY-ESO-1, MAGE-C1/CT7, MAGE-C2/CT10, NSCLC), CureVac
Drug Type
Vaccine
Indication Non-small cell lung cancer [ICD10:C33-C34] Phase 1/2 [522696]
Company
CureVac GmbH
Target and Pathway
Target(s) 5T4 ONCOFETAL antigen Target Info [550441]
Melanoma-associated antigenC2 Target Info [550441]
Baculoviral IAP repeat-containing protein 5 Target Info [550441]
Cancer/Testis Antigen MAGE-C1/CT7 Target Info [550442]
NY-ESO-1 Target Info [550441]
KEGG Pathway Hippo signaling pathway
Hepatitis B
Pathways in cancer
Colorectal cancer
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Angiogenesis
Pathway Interaction Database Aurora B signaling
Validated targets of C-MYC transcriptional activation
FOXM1 transcription factor network
Aurora A signaling
Reactome Separation of Sister Chromatids
Resolution of Sister Chromatid Cohesion
RHO GTPases Activate Formins
Mitotic Prometaphase
WikiPathways IL-4 Signaling Pathway
Apoptosis-related network due to altered Notch3 in ovarian cancer
Mitotic Metaphase and Anaphase
Mitotic Prometaphase
Apoptosis
Interleukin-11 Signaling Pathway
Apoptosis Modulation and Signaling
References
Ref 522696ClinicalTrials.gov (NCT00923312) Trial of an RNActive-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC). U.S. National Institutes of Health.
Ref 550441National Cancer Institute Drug Dictionary (drug id 648549).
Ref 550442National Cancer Institute Drug Dictionary (drug id 648549).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.